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OBJECTIVE: To compare verbal fluency among Alzheimer’s disease, Parkinson’s disease, and major depression and to
assess the sociodemographic and clinical factors associated with the disease severity.
METHODS: Patients from an outpatient university center with a clinical diagnosis of Alzheimer’s disease, Parkinson’s
disease or major depression were studied. Severity was staged using the Hoehn & Yahr scale, the Hamilton
Depression scale and the Clinical Dementia Rating for Parkinson’s disease, major depression, and Alzheimer’s
disease, respectively. All subjects were tested with the Mini-Mental State Examination, the digit span test, and the
verbal fluency test (animals). We fit four types of regression models for the count variable: Poisson model, negative
binomial model, zero-inflated Poisson model, and zero-inflated negative binomial model.
RESULTS: The mean digit span and verbal fluency scores were lower in patients with Alzheimer’s disease (n=34)
than in patients with major depression (n=52) or Parkinson’s disease (n=17) (p,0.001). The average number of
words listed was much lower for Alzheimer’s disease patients (7.2 words) compared to the patients presenting with
major depression (14.6 words) or Parkinson’s disease (15.7 words) (KW test=32.4; p,0.01). Major depression and
Parkinson’s disease groups listed 44% (ROM=1.44) and 48% (ROM=1.48) more words, respectively, compared to
those patients with Alzheimer’s disease; these results were independent of age, education, disease severity and
attention. Independently of diagnosis, age, and education, severe disease showed a 26% (ROM=0.74) reduction in
the number of words listed when compared to mild cases.
CONCLUSIONS: Verbal fluency provides a better characterization of Alzheimer’s disease, major depression, and
Parkinson’s disease, even at later stages.
KEYWORDS: Verbal fluency; cognition; diagnosis; neuropsychology.
Araujo NB, Barca ML, Engedal K, Coutinho ESF, Deslandes AC, and Laks J. Verbal fluency in Alzheimer’s disease, Parkinson’s disease, and major
depression. Clinics. 2011;66(4):623-627.
Received for publication on November 30, 2010; First review completed on December 20, 2010; Accepted for publication on January 17, 2011
E-mail: narahyanaaraujo@yahoo.com.br
Tel.: 55 21 2494 8237
INTRODUCTION
The increasing life expectancy of the population has lead
to a growing number of elderly individuals with major
depression (MD) and dementia worldwide and this trend
has prompted research on the early recognition and
differential diagnosis of these entities in primary care
settings.
1,2 Brief and valid tests, and cognitive batteries
have been developed to screen for
2,3 and differentiate the
diagnoses to better understand the general profiles of these
patient groups.
4,5
The verbal fluency test is a one-minute evaluation that
assesses executive functions as well as linguistic abilities.
6,7
Two subtests are usually applied, the semantic (mainly on
animals)
7,8,9 and the phonetic categories (number of words
begining with the letters F, A, and S in one minute).
14,15
Sociodemographic factors may influence the test perfor-
mance, especially education
6,7,9-12 and age.
6,9,12
Executive dysfunction is a neuropsychological constituent
of dementing illnesses and MD.
13 Parkinson’s disease (PD)
patients usually show executive deficits early in the disease
course, including deficits in information processing, the use
of internal cues for attention and creation of orientation
strategies.
14 The same deficits are applied to patients with
MD, who also present with psychomotor retardation, apathy,
and fluency deficits.
15 Neurodegenerative diseases also
present with marked changes in the ability to generate and
understand words, sentences, and language as a whole. In
both Alzheimer’s disease (AD) and PD, the verbal fluency
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623test results usually differ from those of healthy elderly,
16,17
although the neural pathways may differ between diseases in
terms of the differences in the test.
18-21 Several studies have
evaluated verbal fluency in these three diseases separately,
but only a few have compared the test results among the
three disorders.This direct comparison couldprovidefurther
data that would allow these disorders to be characterized in a
quick and valid way from a cognitive standpoint. Therefore,
we studied whether verbal fluency scores would differ
betweenAD,PD,andMDpatients.WehypothesizedthatAD
patientswouldexhibitthelowestscoreswhiletherewouldbe
no significant differences between PD and MD scores. We
also assessed which sociodemographic and clinical factors
influenced the results.
MATERIALS AND METHODS
Patients from an outpatient university center who had a
clinical diagnosis of AD according to DSM-IV
22 and
NINCDS-ADRDA,
23 PD according to the United Kingdom
Parkinson Disease Society Brain Bank
24 and the Unified
Parkinson’s disease rating scale (UPDRS),
25 and MD
according to DSM-IV criteria using the Structured Clinical
Interview for DSM Disorders (SCID) were recruited for the
study from an outpatient university center. Subjects with
comorbid psychiatric, neurological, or clinical disorders
were excluded from the sample, as well as those patients
who presented with important physical limitations and
visual or hearing impairment. None of the PD patients
included in this study had a clinical diagnosis of dementia
after thorough clinical, biochemical and neuroimaging
examinations. A total of 103 patients older than 45 years
of age were included in the final sample (n=34 AD, n=17
PD, and n=52 MD).
To stage the severity of each disorder, the Brazilian
validated versions of the Hoehn & Yahr scale
26 (stages 1 to
3), the Hamilton Depression scale
27 (cutoff scores - mild: 8-
13; moderate: 14-18; severe: 19-22), and the Clinical
Dementia Rating
28 were used for PD, MD, and AD patients,
respectively. All subjects were assessed with a sociodemo-
graphic interview and the Mini Mental State Examination
(MMSE),
29 the digit span subtest of the WAIS-R,
30 and the
verbal fluency test using the animal category.
31
The MMSE is a brief screening test for cognitive
capabilities that evaluates orientation (spatial and time),
attention, concentration, memory, calculation, language,
and praxis. The score ranges from 0 to 30, with higher
scores indicating better performance.
32
The digit span subtest
30 assesses immediate memory and
attention. A series of number sequences are presented to the
subject. In the first portion of the test, the subject is asked to
reproduce the exact sequence, whereas in the second
portion he/she is asked to repeat the sequence backwards.
29
The verbal fluency testis a one-minute assessment in which
the patient is asked to name as many animals as he can.
11
Repeated words are not counted towards the final score.
A descriptive statistic was initially calculated for the
demographic and clinical characteristics of the patients for
each diagnosis. The statistical significance of differences
between means was estimated with the Kruskal-Wallis test.
The exploratory analysis of verbal fluency scores suggested
an excess of zeros in the frequency distribution of this
variable. We fitted four types of regression models for the
count variable: the Poisson model (PRM), the negative
binomial model (NRBM), the zero-inflated Poisson model
(ZIP) and the zero-inflated negative binomial model (ZINB).
Tests, plots and fit statistics were performed, and the ZINB
model yielded the best results. This model assumes that the
studied population comprises two sets of individuals: one
consisting of subjects with a high propensity to list words
and another consisting of individuals with a high chance of
having difficulty listing at least one word. The ZINB model
assumes that various underlying processes can be involved
in producing zero and non-zero counts. The exponential
transformation of the coefficient of the negative binomial
component (count part) estimates the average number of
listed words associated with the selected explanatory
variables. However, the exponential transformation of the
coefficient provided by the logistic component (inflate part)
of the model estimates the odds ratio for the chance of
belonging to the group of individuals with difficulty listing
at least one word.
33,34
The alpha dispersion parameter was calculated for the
count model. If this parameter is close to zero, the model
converges to a Poisson distribution. The Vuong test was
used to compare the zero-inflated negative binomial to the
standard negative binomial model.
34 The Akaike’s informa-
tion criterion (AIC), Bayesian information criterion (BIC)
and Likelihood Ratio (LR) chi-squared statistics were also
used to compare the goodness of fit between the different
models. The analysis was conducted using Stata 10.0.
This study was approved by the Ethics Committee of the
Institute of Psychiatry of the Federal University of Rio de
Janeiro, and all participants signed informed consent forms
before any procedures.
RESULTS
The study population consisted of 103 patients. Table 1
presents the distribution of the group according to demo-
graphic and clinical characteristics.
Most patients were women and had less than 9 years of
education. MD was the largest diagnostic group, and the
disease was considered severe in approximately 1/5 of the
sample. The mean MMSE of the AD patients was the lowest
and was significantly different from the other diagnoses
(p,0.001). The mean Digit Span and verbal fluency scores of
the AD patients were smaller and lower, respectively,
compared to the scores for those patients with MD and PD
(p,0.001). Table 2 shows the pattern of disease severity for
the individuals in each disease group. While AD and MD
patients were classified predominantly as mild cases, those
patients withPD were predominantly in the moderate group.
Verbal fluency test results differed between diagnostic
groups. The average number of words listed was much lower
for AD patients (7.2 words) than for those patients presenting
MD (14.6 words) or PD (15.7 words). This difference was
statistically significant (KW test=32.4; p,0.01).
Table 3 presents the parameters for the count and inflate
components of the ZINB model. For the count component
(average number of words listed), the MD and PD groups
had 44% (ratio of means [ROM]=1.44) and 48% (ROM=1.48)
more words listed, respectively, in one minute compared to
AD patients. This association was independent of age,
education, severity and attention.
The PD and MD groups only differed by 2% in the
average number of words listed, and this difference did not
reach statistical significance (p=0.80).
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was also inversely associated with verbal fluency. Severe
cases, independently of diagnosis, age and education,
showed a 26% (ROM=0.74) reduction in the number of
words listed compared to mild cases. We observed no
statistically significant difference in verbal fluency results
between the moderate and mild cases.
The performance on the digit span test was associated
with verbal fluency as measured in the two components of
the model. For each one-point increase in the digit span,
there was a 6% (ROM=1.06) increase in the number of
words listed in one minute. Only the digit span test
influenced verbal fluency in the inflate component of the
ZINB model (chance of not listing at least one word). We
observed a 62% reduction in the chance of being unable to
list at least one word for each one-point increase in the digit
span test score (OR=0.38).
Although age and education were not associated with
verbal fluency in this sample, they were retained in the final
model as a confounding control.
When the MMSE scores were included in the model,
diagnosis and severity lost their association with verbal
fluency due to collinearity. Digit span remained associated
with higher verbal fluency (ROM=1.04; p=0.01).
The log of the alpha and Vuong tests were statistically
significant, suggesting data dispersion and an excess of
zeros and increasing the appropriateness of the ZINB model
compared to the negative binomial model for these data.
Figure 1 depicts the fit of the PRM, NBRM, ZIP and ZINB
regression models. Although the figure shows a very similar
pattern of residuals for both ZINB and ZIP models, AIC and
LR chi-squared statistics suggested that the ZINB model
presents a slightly better fit than ZIP.
DISCUSSION
As expected, the performance of AD patients in the verbal
fluency test was significantly lower than the performance
observed in both PD and MD patients. The AD group
averaged half the number of words observed for PD and
MD patients. Our results also showed that disease severity
has a direct impact on verbal fluency, regardless of the
diagnosis, age, educational level, or gender. Overall,
patients in the more severe stage generated 26% fewer
words than those patients in the mild and moderate stages.
Moreover, attention and concentration seem to play an
important role in performance because the digit span test
both reduces the chance of being unable to say at least one
word and also increases the average number of listed
words.
Healthy elderly people with lower levels of education in
Brazil are expected to generate a mean of nine words, as
Table 1 - Demographic and clinical characteristics of the
patients (n=103).
Characteristics Diseases
Alzheimer’s
N=34
Depression
N=52
Parkinson’s
N=17
Gender (female)
N (%) 24 (70.6) 45 (86.5) 5 (29.4)
Age (years)
*
Mean (SD
1) 74.3 (8.9) 71.4 (5.9) 64.2 (9.3)
Median 76.5 70.5 64.0
Range 54-90 60-87 45-77
Years of education
2
Mean (SD) 5.7 (3.9) 7.8 (3.9) 7.9 (4.9)
Median 5.0 7.5 6.0
Range 1-17 2-16 3-15
MMSE
***
Mean (SD) 14.0 (8.8) 27.1 (3.0) 25.6 (3.5)
Median 15.0 28.0 25.0
Range 0-30 17-30 21-30
Digit Span Test
3
Mean (SD) 4.7 (3.1) 8.9 (3.0) 9.3 (3.1)
Median 4.5 8.5 9.0
Range 0-11 4-18 5-14
Verbal Fluency Test
(words)
4
Mean (SD) 7.2 (6.0) 14.6 (3.7) 15.7 (5.8)
Median 7.0 14.0 15.0
Range 0-21 7-26 6-27
(
1) Standard deviation.
(*) Age: Alzheimer’s disease vs. depression: p=0.04; depression vs.
Parkinson’s disease: p=0.003; Alzheimer’s vs. Parkinson’s disease:
p,0.001.
(**) Years of education: Alzheimer’s disease vs. depression: p=0.005;
depression vs. Parkinson’s disease: p=0.79; Alzheimer’s vs. Parkinson’s
disease: p=0.09.
(***) MMSE (Mini-Mental State Examination): Alzheimer’s disease vs.
depression or Parkinson’s disease: p,0.001; depression vs. Parkinson’s
disease: p=0.09.
(****) Digit span test: Alzheimer’s disease vs. depression or Parkinson’s
disease: p,0.001; depression vs. Parkinson’s disease: p=0.63.
(*****) Verbal fluency test: Alzheimer’s disease vs. depression or
Parkinson’s disease: p,0.001; depression vs. Parkinson’s disease: p=0.35.
Table 2 - Disease severity according to diagnosis.
Diagnosis
Mild form
N (%)
Moderate
form N (%)
Severe form
N (%)
Alzheimer’s disease 16 (47.1) 9 (26.5) 9 (26.5)
Major Depression 24 (53.3) 14 (31.1) 7 (15.6)
Parkinson’s disease 3 (17.7) 9 (52.9) 5 (29.4)
Table 3 - Zero-inflated negative binomial regression of
verbal fluency scores according to demographic and
clinical variables.
Variable ROM* 95% CI P-value
Count for verbal fluency
score.
Diagnosis
Alzheimer’s disease Reference
Depression 1.44 1.20 to 1.73 ,0.001
Parkinson’s disease 1.48 1.15 to 1.89 0.002
Disease severity
Mild Reference
Moderate 0.96 0.82 to 1.11 0.58
Severe 0.74 0.60 to 0.92 0.01
Digit Span test 1.06 1.04 to 1.09 ,0.001
Age 1.00 0.99 to 1.01 0.78
Education (years) 0.95 0.89 to 1.02 0.14
Gender (female) 0.88 0.75 to 1.04 0.14
OR** of verbal fluency
score =0
Digit Span test 0.38 0.21 to 0.70 0.002
Constant 3.77 0.63 to 22.37 0.14
Log alpha =-3.93 (p, 0.001); alpha =0.02.
Vuong test of ZINB vs. standard negative binomial: z=2.23 (Pr.z=0.01).
(*) The ratio of means expresses the difference in the number of words
listed in one minute as a ratio.
(**) Odds ratio.
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625opposed to 13 words by those healthy elderly with more
than eight years of education.
30 Thus, the results for the PD
and MD groups in our study are within the normal ranges
for the Brazilian elderly population. These results are
consistent with research that found that AD patients have
a decreased performance in verbal fluency compared to
non-demented PD patients
35 and MD elderly.
21 The
preservation of functional areas related to language and
semantic knowledge is key to achieving a normal perfor-
mance on the verbal fluency test.
36 However, subcortical
disorders, such as PD, and disorders, such as MD, which are
related to a decreased activity in orbital
13,37 and dorsal
lateral frontal areas,
13,37 could show some impairment of
verbal fluency by different mechanisms from the one shown
by AD patients. Two recent meta-analyses have shown that
semantic verbal fluency is significantly reduced in AD
patients when compared to MD and PD patients.
14,21 In
addition, one of these studies presented data confirming
that semantic fluency in depression is not only related to
executive impairment but could also be a sign of a broader
impairment in terms of neural circuits.
21
Similar to other studies,
18,19 we found that verbal fluency
decreases as the three diseases progress in severity. This
result then raises the question of whether the verbal fluency
test would also be able to better characterize these three
entities at later stages of the disease. As shown in Table 3,
we found that differences in semantic verbal fluency are
present even at the more severe stages.
This study has some limitations that should be acknowl-
edged. The cross-sectional design does not allow us to make
a conclusion on the nature of the real outcome of verbal
fluency as the diseases progress in severity. Longitudinal
studies measuring verbal fluency can provide a more
complete picture than the present paper. Another important
limitation is that the measurement of severity of the three
disorders requires distinct instruments. In fact, the severity
of dementia is mostly assessed based on cognitive and
functional status, whereas PD is rated by taking motor
symptoms into account, and MD severity relies on the
intensity of emotional and physiological symptoms. The
small number of participants and the absence of a healthy
control group are other important limitations of this study.
However, to the best of our knowledge, this is the first study
to assess and compare verbal fluency among AD, PD, and
MD patients. This study presented the clinically relevant
finding that verbal fluency is worse in AD patients when
compared to MD and PD patients, even when the three
disorders are at their most severe stages.
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